Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers (8669-010)(COMPLETED)
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, and recommended phase 2 dose
of oral ridaforolimus administered in combination with intravenous bevacizumab in patients
with advanced cancers.